You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
兩連板的海正藥業(600267.SH):目前法維拉韋片銷售收入佔比較小
格隆匯 03-19 22:03

格隆匯3月19日丨連續2個漲停的海正藥業(600267.SH)發佈公告稱,截至目前,公司獲得法維拉韋片的《藥品註冊批件》僅適用於治療成人新型或再次流行的流感。

公司獲得的法維拉韋片的《藥物臨牀試驗批件》針對新適應症,目前臨牀試驗正在進行中,後續待完成一系列臨牀試驗步驟後還需提交審評審批,臨牀試驗結果存在不確定性,能否取得新適應症的生產註冊存在不確定性。

截至目前,法維拉韋片銷售收入佔公司收入比重較小,對公司當期業績影響亦較小。

公司敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account